Starpharma Holdings Limited
SPL
Rank in Stocks
#18318
Starpharma Holdings Limited is a biopharmaceutical enterprise focused on the... Starpharma Holdings Limited is a biopharmaceutical enterprise focused on the research, development, and global commercialization of dendrimer-based products for the pharmaceutical, life sciences, and other industries. Its current offerings include VivaGel, a non-antibiotic treatment and preventative measure for bacterial vaginosis. The company also provides the antiviral VivaGel condom and VIRALEZE, an antiviral nasal spray. Furthermore, Starpharma is actively progressing its DEP (dendrimer drug delivery) technology platform. This platform supports multiple oncology candidates in clinical development, such as DEP docetaxel (Phase 2), DEP cabazitaxel (Phase 2), DEP gemcitabine (Phase 1/2), and DEP irinotecan (Phase 2), all aimed at treating cancer. The DEP technology is also being applied to radiotheranostics for cancer diagnosis and therapy, Antibody Drug Conjugates (including DEP HER-2 ADC), and non-oncology programs. Additionally, DEP AZD0466 is currently in Phase 1/2 clinical trials for haematological malignancies. Founded in 1996, the company maintains its headquarters in Abbotsford, Australia.
Share Price
$0.28379791
Last synced: 2026-11-10
Market Cap
$137.05M
Change (1 day)
-7.87%
Change (1 year)
12.96%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Starpharma Holdings Limited (SPL)
Category
Healthcare
Operating Margin for Starpharma Holdings Limited (SPL)
Operating Margin as of November 2026 TTM: -159.60%
According to Starpharma Holdings Limited's latest financial reports, its current operating margin (TTM) is -159.60%. At the end of 2025 the company had an operating margin of -244.26%.
Operating Margin history for Starpharma Holdings Limited from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -159.60% | -34.66% |
| 2025 | -244.26% | 33.56% |
| 2024 | -182.88% | -78.22% |
| 2023 | -839.50% | 64.49% |
| 2022 | -510.36% | -67.99% |
| 2021 | -1,594.49% | 348.90% |
| 2020 | -355.20% | -32.22% |
| 2019 | -524.04% | 152.57% |
| 2018 | -207.48% | -50.27% |
| 2017 | -417.25% | -10.36% |
| 2016 | -465.46% | -58.31% |
| 2015 | -1,116.38% | -4.37% |
| 2014 | -1,167.44% | -97.31% |
| 2013 | -43,420.00% | 2,175.30% |
| 2012 | -1,908.32% | 73.19% |
| 2011 | -1,101.84% | 23.13% |
| 2010 | -894.87% | 27.92% |
| 2009 | -699.55% | -47.25% |
| 2008 | -1,326.27% | -37.95% |
| 2007 | -2,137.46% | -99.92% |
| 2006 | -2,770,216.40% | 547,146.48% |
| 2005 | -506.21% | -2.81% |
| 2004 | -520.84% | -1.76% |
| 2003 | -530.15% | -77.00% |
| 2002 | -2,305.25% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.24% |
US
|
|
| -149.01% | -99.07% |
US
|
|
| 25.57% | -100.16% |
AU
|
|
| 31.23% | -100.20% |
BE
|
|
| 29.35% | -100.18% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Starpharma Holdings Limited's operating margin
What is Starpharma Holdings Limited's operating margin?
Starpharma Holdings Limited's operating margin is -159.60%, as of Nov 2026.
What was Starpharma Holdings Limited's operating margin in 2025?
In 2025, Starpharma Holdings Limited's operating margin was -244.26%, compared with -182.88% in 2024.
How has Starpharma Holdings Limited's operating margin changed since 2020?
From 2020 to 2025, Starpharma Holdings Limited's operating margin was highest in 2024 (-182.88%) and lowest in 2021 (-1,594.49%).
How does Starpharma Holdings Limited's operating margin compare with similar companies?
Starpharma Holdings Limited's operating margin (-159.60%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.